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Objectives. This study sought to investigate the independent
effect of ethnicity on the utilization of invasive cardiac procedures
after acute myocardial infarction (AMI).
Background. The precise role of ethnicity in access to cardio-
vascular procedures is unknown, particularly because of difficulty
in isolating ethnicity from financial and other socioeconomic
factors. We conducted a retrospective analysis of the use of
cardiac catheterization and coronary revascularization proce-
dures after AMI in military health care beneficiaries. The Military
Health Services System (MHSS) ensures equal access to care in
an environment without financial incentives for procedural utili-
zation; furthermore, socioeconomic differences between patients
beyond ethnicity are minimized.
Methods. Data were analyzed from the Civilian External Peer
Review Program representing abstracted chart reviews from 125
military health care facilities worldwide for all patients (1,208
white; 233 nonwhite [155 black]) with the principal or secondary
diagnosis of AMI from March to September 1993.
Results. Rates of cardiac catheterization were similar in white
and nonwhite patients (34.8 vs. 39.1%, p 5 0.21). After controlling
for age, gender, cardiovascular risk factors and AMI variables,
including infarct size and other risk markers, there were no
differences in the use of this procedure during the AMI admission
in comparisons of white versus nonwhite patients (estimated odds
ratio [OR] 0.96, 95% confidence interval [CI] 0.69 to 1.34) and
white versus black patients (OR 1.19, 95% CI 0.80 to 1.78).
However, white patients were significantly more likely than non-
white patients to be “considered” for future cardiac catheteriza-
tion (OR 1.77, 95% CI 1.19 to 2.61). Coronary revascularization
within 180 days was not significantly affected by race in white
versus nonwhite (OR 0.90, 95% CI 0.59 to 1.39) and white versus
black patients (OR 1.11, 95% CI 0.65 to 1.89). Outcomes (30- and
180-day mortality and readmission rates) were similar for all race
groups.
Conclusions. There is a limited relation between ethnicity and
the use of invasive cardiac procedures in the MHSS. These data
raise the promise that characteristics of a health care system can
mitigate ethnic bias in medicine.
(J Am Coll Cardiol 1997;30:901–7)
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The relation between race and access to invasive cardiovascu-
lar procedures has been examined in multiple studies over the
past three decades (1–11). These studies have uniformly
identified racial bias in the access to a variety of cardiovascular
procedures, including cardiac catheterization, percutaneous
transluminal coronary angioplasty (PTCA) and coronary artery
bypass graft surgery (CABG). In general, white patients have
been described to be 1.3 to 4.5 times as likely to undergo these
procedures as nonwhite (principally black) patients. Disap-
pointingly, despite the identification of potential racial bias and
efforts to increase awareness of this problem within the
medical community over this period, even recent studies
continue to show this disturbing finding (8–12).
Over the same three decades, there has been an ongoing
debate regarding the etiology of racial bias in medicine,
particularly with respect to cardiovascular procedures. At the
core of this debate is the implication that bias in the access to
cardiovascular procedures is a matter of race, specifically by
racial bias against nonwhite individuals. Beyond this presump-
tion, the search for other possible causes has been inconclusive
to date due to either limitations of existing studies or the
possibility of other postulated, yet difficult to measure factors.
These include local biases arising from data generated from a
single center or region, an inability to adequately control for
economic factors, differences in medical training or practice
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patterns, differences in the level of insurance, remunerative
concerns of practitioners, limitations in the amount of clinical
data in predominantly administrative databases and patient
perceptions on acceptance of invasive procedures (12). Thus, it
remains unclear whether race or other factors are important
determinants of the observed differential access to care in
white and nonwhite patients.
The Military Health Services System (MHSS) currently
serves approximately 9 million beneficiaries, including active
duty military personnel, their dependents and retirees, and
tracks demographic, diagnostic and procedural data from
inpatient admissions in the 125 military treatment facilities
worldwide. Although data from the MHSS share many of the
strengths of administrative datasets, such as those created by
the Veterans Affairs Medical System (VAMS) and Medicare,
the MHSS database has a number of potential advantages over
civilian systems, including a personnel system that can track
patients accurately over time and space; excellent socioeco-
nomic adjusters through the recording of sponsor rank; a
broad representation of patient demography in terms of age,
gender and location; and the absence of economic barriers and
remunerative incentives to influence coding procedures. Thus,
the characteristics of the MHSS address many of the limita-
tions of past studies on the issue of ethnic bias in access to
invasive cardiac procedures. Accordingly, we conducted a
retrospective analysis of this issue in military health care
beneficiaries after acute myocardial infarction (AMI). We
hypothesized that within the MHSS, specific characteristics of
the health care system, including health care access that is
equal and ensured as a right of beneficiary status and limited
socioeconomic differences between patients, would nullify an
independent association of race and the utilization of invasive
cardiovascular procedures.
Methods
Patient selection. In 1986 the Department of Defense
initiated the Civilian External Peer Review Program (CEPRP)
to provide external oversight of the care provided through the
MHSS (13). The CEPRP focused on specific, predefined
surgical, procedural and medical diagnoses; initiated chart
abstractions of comprehensive, date-defined patient samples;
and analyzed the standards of care in the MHSS compared
with civilian norms. In the area of cardiovascular medicine, the
CEPRP was tasked to specifically examine the use of cardiac
catheterization and coronary artery revascularization proce-
dures after AMI.
Among the activities of the CEPRP was an assessment of
care for patients with AMI. Charts of all patients (n 5 1,441)
discharged from military treatment facilities with a diagnosis of
AMI during the period from March to September 1993 were
studied. After confirmation of the diagnosis of AMI based on
elevation of total creatine kinase (CK) levels .200 U/ml and
MB bands above the stated normal for the medical treatment
facility under review, charts were abstracted by professional
nurse abstractors for relevant clinical and demographic infor-
mation. In 10 cases, clinical data were missing altogether (e.g.,
there were no procedures coded from the chart abstraction),
and these were excluded from the analysis.
Demographic and clinical data. The data elements ab-
stracted included patient demographics, including gender, age,
race (coded as white, black, Asian, American Indian, hispanic
or multiracial), military affiliation, beneficiary status (active
duty, dependent or retired) and military rank of the sponsor
(providing a measure of relative social, educational and eco-
nomic status). Race was determined from the self-reported
race, as listed in the Defense Eligibility and Enrollment
System. Ethnicity was analyzed as white versus black race and
white versus nonblack ethnic origin (12). Hispanics were
grouped under the category of nonblack ethnic origin. The
beneficiary status of the study group included 90 active duty
military personnel (6.2%), 38 dependents of active duty mili-
tary personnel (2.6%), 331 retired service members (23.0%),
915 dependents of retired service members (63.5%) and 67
other (4.6%) (including foreign diplomats). Military rank was
used as a surrogate for socioeconomic status and educational
level and was considered both a binary variable of income of
$$30,000/year or ,$30,000/year and as a categoric variable in
$5,000/year increments.
The clinical data collected included the presence of cardiac
risk factors, such as diabetes, hypercholesterolemia, hyperten-
sion, tobacco use and previous AMI. Clinical data relevant to
the admission for AMI included the presence and duration of
chest pain, electrocardiographic abnormalities, use of throm-
bolytic agents, blood pressure, peak CK value, ventricular
arrhythmias, atrioventricular conduction block (Mobitz II or
third degree) and congestive heart failure. Data on the post-
AMI evaluation included the performance and ability to
undergo stress testing and the performance and timing of
cardiac catheterization, PTCA and CABG. Cardiac catheter-
ization was coded as either performed during the hospital
period or being considered to be performed within the subse-
quent 3 months. This group, for whom a chart notation to
consider possible cardiac catheterization or future planned
cardiac catheterization was made, represents a subgroup
unique to this dataset.
Procedural and outcome data. Outcome variables coded
included length of hospital stay and in-hospital mortality. To
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CABG 5 coronary artery bypass graft surgery
CEPRP 5 Civilian External Peer Review Program
CHAMPUS 5 Civilian Health and Medical Program of the
Uniformed Services
CK 5 creatine kinase
DRGs 5 diagnosis-related groups
MHSS 5 Military Health Services System
NHDS 5 National Hospital Discharge Survey
PTCA 5 percutaneous transluminal coronary angioplasty
VAMS 5 Veterans Affairs Medical System
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complete outcome data beyond that available through the
CEPRP, our dataset was linked using unique patient identifiers
to the Retrospective Case Mix Analysis System (a Department
of Defense information system similar to the Medicare Part A
files) to identify all readmissions and invasive cardiac proce-
dures performed within 180 days of the index admission.
Included in these data are procedures and admissions at both
military health care and civilian facilities through the Civilian
Health and Medical Program of the Uniformed Services
(CHAMPUS). Late deaths (within 180 days) were identified
through the Defense Eligibility and Enrollment Registration
System. No patient was lost to administrative follow-up
through these databases.
Statistical analysis. The chi-square test with Yates correc-
tion was used to evaluate the relation of ethnicity to individual
patient variables, interventions and outcomes. The two-tailed t
test was used to analyze for differences in continuous variables
(age and peak CK). To control for multiple variables simulta-
neously, logistic regression analysis was used to estimate odds
ratios for the role of ethnicity in the use of invasive cardiac
procedures and its effect on outcome controlling for potential
confounders. Multivariate stepwise analysis was performed
with the end points of this study (cardiac catheterization,
coronary revascularization and mortality) as dependent vari-
ables and race as the independent variable of interest. Our
models treated risk factors for coronary artery disease (age,
gender, diabetes, hypertension, hypercholesterolemia, smok-
ing and previous AMI), clinical factors (use of thrombolytic
agents, ST segment elevation on presentation, congestive heart
failure, heart block, performance of stress testing and CK
levels) and socioeconomic characteristics (beneficiary category
and military rank) as independent variables. We considered a
two-tailed p value of 0.05 to be statistically significant. All
analyses were performed with the STATA statistical package
(STATA v.4, STATA, College Station, Texas).
Results
Patient data. Overall, 1,441 patients with a confirmed AMI
(1,208 white, 233 nonwhite [155 black, 78 of nonblack ethnic
origin]) were identified during the study period. The mean
[6SD] patient age was 62.4 6 11.4 years, and 73.4% of the
study cohort was male. Baseline characteristics of the study
cohort are indicated in Table 1. Overall, white and nonwhite
Table 1. Clinical Characteristics of the Study Patients
White
(n 5 1208)
Black
(n 5 155)
Other
(n 5 78)
Age (yr) 63.1 6 11.1 57.7 6 12.7* 60.6 6 12.1*
Male gender 894 (74.0) 111 (71.6) 53 (68.0)
Hypertension 550 (45.5) 104 (67.1)* 36 (46.2)
Diabetes mellitus 305 (25.2) 43 (27.7) 26 (33.3)
Hypercholesterolemia 269 (22.3) 35 (22.6) 19 (24.4)
Tobacco use 101 (8.4) 12 (7.7) 4 (5.1)
Previous myocardial infarction 78 (6.5) 7 (4.5) 7 (9.0)
Hospital period variables
Thrombolytic therapy 282 (23.3) 37 (23.9) 18 (23.1)
Peak creatine kinase (U/liter) 1,038 6 1,231 1,259 6 1,818 1,047 6 1,096
Congestive heart failure 221 (18.3) 34 (21.9) 17 (21.8)
Ventricular arrhythmias 89 (7.4) 15 (9.7) 11 (14.1)
Heart block (Mobitz II or 3rd degree) 29 (2.4) 5 (3.2) 2 (2.6)
Unable to perform exercise test 324 (26.8) 27 (17.4) 24 (30.8)
Cardiac catheterization
During initial hospital period 420 (34.8) 56 (36.1) 35 (44.9)
30 days 503 (41.6) 67 (43.2) 37 (47.4)
180 days 528 (43.7) 74 (47.7) 38 (48.7)
Coronary revascularization
PTCA
Initial hospital period 68 (5.6) 5 (3.2) 6 (7.7)
180 days 151 (12.5) 19 (12.3) 19 (24.4)†
CABG
Initial hospital period 149 (12.3) 15 (9.7) 12 (15.4)
180 days 156 (12.9) 15 (9.7) 12 (15.4)
Outcome
Hospital mortality 139 (11.5) 14 (9.0) 11 (14.1)
30-day mortality 162 (13.4) 14 (9.0) 13 (16.7)
180-day mortality 184 (15.2) 17 (11.0) 13 (16.7)
Hospital readmission (within 180 days) 51 (4.2) 5 (3.2) 3 (3.8)
*p , 0.001. †p , 0.01. Data presented are mean 6 SD or number (%) of patients. CABG 5 coronary artery bypass
graft surgery; PTCA 5 percutaneous transluminal coronary angioplasty.
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patients were comparable with respect to the prevalence of
diabetes mellitus, hypercholesterolemia, tobacco use and pre-
vious AMI. However, white patients were older than both
black patients and patients of nonblack ethnic origin (63.1 6
11.1 vs. 57.7 6 12.7 and 60.6 6 12.1 years, respectively, p ,
0.001 for both comparisons). Black patients were significantly
more likely than white patients to have hypertension (67.1% vs.
45.5%, p , 0.001).
Cardiac catheterization. During the index admission for
AMI, univariate comparisons indicated that cardiac catheter-
ization was performed in 34.8% of white patients, 36.1% of
black patients and 44.9% of patients of nonblack ethnic origin
(p 5 NS for all comparisons vs. white race). These nonsignif-
icant differences were diminished by 180 days, by which 43.7%
of white patients, 47.7% of black patients and 48.7% of
patients of nonblack ethnic origin had undergone cardiac
catheterization (p 5 NS for all comparisons). Logistic regres-
sion was performed to control for multiple patient and AMI
variables that might have influenced the rates of cardiac
catheterization. The estimated odds ratios for cardiac cathe-
terization up to 180 days after the index AMI for white versus
nonwhite patients, white versus black patients and white versus
nonblack ethnic patients are displayed in Table 2. For com-
parisons of white and nonwhite patients, the estimated odds
ratios for the influence of ethnicity on rates of cardiac cathe-
terization were near 1 for both catheterization during the
initial hospital period (odds ratio [OR] 0.96, 95% confidence
interval [CI] 0.69 to 1.34, p 5 0.83) and cumulatively up to 180
days after AMI (OR 1.07, 95% CI 0.77 to 1.49, p 5 0.67). As
indicated, although the estimated odds ratio estimates were
comparable for subgroup comparisons of white patients with
black and nonblack ethnic patients, small sample sizes limit the
precision of these estimates.
Factors related to the use of cardiac catheterization were
explored (Fig. 1). An increased likelihood of cardiac catheter-
ization during the initial hospital period was related to ST
segment elevation on the admission electrocardiogram (OR
1.31, 95% CI 1.00 to 1.72, p 5 0.047), having undergone an
exercise tolerance test after AMI (OR 2.50, 95% CI 1.94 to
3.23, p , 0.001), the presence of hypercholesterolemia (OR
1.51, 95% CI 1.13 to 2.01, p 5 0.005) and higher peak CK value
(OR 1.03 per 250 U/liter increment in peak CK value, 95% CI
1.01 to 1.05, p 5 0.03). Conversely, the estimated odds ratios
related to smoking (OR 0.62, 95% CI 0.39 to 0.98, p 5 0.04)
and the presence of congestive heart failure (OR 0.57, 95% CI
0.40 to 0.80, p 5 0.001) indicated that cardiac catheterization
was significantly less likely under these circumstances.
Although the rates of utilization of cardiac catheterization
were similar in white and nonwhite patients, data were col-
lected from abstracted charts according to whether catheter-
ization was being “considered” in the future. Overall, 348 such
patients were identified, with a tendency for this designation to
be found more commonly in white than nonwhite patients
(25.0% vs. 19.8%, p 5 0.09). After controlling for multiple
patient and AMI variables, the estimated odds ratio for
“consider cath” in white versus nonwhite patients was 1.77
(95% CI 1.20 to 2.61, p 5 0.003). Comparable estimated odds
ratios were observed for subgroup comparisons of white with
black and nonblack ethnic patients. However, although white
patients were “considered” for cardiac catheterization more
frequently, subsequent catheterization in the 180 days after
hospital discharge in this subgroup of patients was infrequently
performed (n 5 87 [25.0%]) and late mortality (within 180
days) in this subgroup was uncommon (n 5 15 [4.3%]).
Coronary revascularization procedures. PTCA was per-
formed during the initial hospital period at a comparable rate
in all three racial groups (Table 1). However, patients of
nonblack ethnic origin underwent late PTCA significantly
more frequently than white patients (24.4% vs. 12.5%, p 5
0.003). PTCA was comparably performed in white and black
patients (12.5% vs. 12.3%, respectively, p 5 0.93). There were
no significant differences between white and nonwhite patients
in frequency of CABG. Logistic regression was performed to
control for multiple patient and AMI variables that might have
influenced the use of revascularization procedures in white
versus nonwhite patients and white versus black patients
(Table 2). The estimated odds ratio for the influence of white
Table 2. Estimated Odds Ratios for Cardiac Catheterization and
Coronary Revascularization According to Ethnic Group in Patients
with Acute Myocardial Infarction in the Civilian External Peer
Review Program
Outcome
Estimated OR*
(95% CI)
p
Value
Cardiac catheterization
White vs. nonwhite pts
Initial hosp 0.96 (0.69–1.34) 0.83
Within 180 days 1.07 (0.77–1.49) 0.67
White vs. black pts
Initial hosp 1.19 (0.80–1.78) 0.39
Within 180 days 1.20 (0.81–1.78) 0.35
White vs. nonblack ethnic pts
Initial hosp 0.67 (0.40–1.12) 0.13
Within 180 days 0.89 (0.53–1.50) 0.65
Revascularization within 180 days
White vs. nonwhite pts
Any revasc 0.90 (0.59–1.39) 0.65
PTCA 0.84 (0.51–1.38) 0.49
CABG 1.28 (0.75–2.16) 0.38
White vs. black pts
Any revasc 1.11 (0.65–1.89) 0.72
PTCA 1.11 (0.59–2.1) 0.74
CABG 1.48 (0.75–2.93) 0.26
White vs. nonblack ethnic pts
Any revasc 0.66 (0.34–1.26) 0.21
PTCA 0.56 (0.27–1.17) 0.12
CABG 1.01 (0.46–2.21) 0.98
*Estimated odds ratios were derived by multiple logistic regression, with
each ratio adjusted for patient demographic and acute myocardial infarction
variables (see Methods). An estimated odds ratio ,1 indicates that a white
patient was less likely to experience the indicated outcome than a nonwhite
patient with the same characteristics, and a ratio .1 indicates that white patients
had a higher odds. CI 5 confidence interval; hosp 5 hospital period; OR 5 odds
ratio; pts 5 patients; revasc 5 revascularization; other abbreviations as in Table
1.
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versus black race on the use of any revascularization procedure
performed within 180 days of AMI was 1.11 (95% CI 0.65 to
1.89, p 5 0.72). The limited numbers of these procedures in
nonblack ethnic patients limit the precision of the estimated
odds ratios for revascularization in this group.
Outcome data. Outcomes measured by mortality and hos-
pital readmissions were also analyzed (Tables 1 and 3). Mor-
tality rates were slightly higher in white versus nonwhite
patients, both in-hospital (11.5% vs. 10.7%, p 5 0.73) and at
180 days after AMI (15.2% vs. 12.9%, p 5 0.36), but these
differences were not statistically significant. Similarly, 180-day
hospital readmission rates were comparable in both groups
(white patients 4.2%, nonwhite patients 3.4%, p 5 0.58).
Multiple regression analysis found no significant relation be-
tween ethnic group and 30-day mortality, as well as mortality
and readmissions at 180 days, after controlling for cardiac risk
factors and AMI variables.
Role of military status and rank as a surrogate of income.
Separate analyses were performed for rates of procedural and
outcome variables according to military status and rank, as an
index of income. In no case was military status or rank a
significant contributor to the logit models.
Discussion
Previous data on the impact of race on access to cardiovas-
cular procedures have been consistent in the finding of bias
against nonwhite patients; thus, the existence of a “racial” bias
is generally accepted. Past studies have indicated that the odds
ratio for cardiac catheterization in a white patient with sus-
pected ischemic heart disease is ;1.4 times greater than in a
nonwhite patient, although some reports (1,2) have found the
odds ratios to be as high as 2. Similar, if not greater, degrees of
disparity have been found in access to other cardiovascular
procedures, such as PTCA or CABG (1,14). Despite these
results, separating race from other factors has proved difficult.
The separation of race from socioeconomic status has relied on
analyses from health care systems possessing distinct charac-
teristics, such as the VAMS, yet such data are often limited by
the depth of clinical information contained or by other factors.
The present study. Our extensive administrative and clini-
cal data indicate that within the MHSS, where access to
medical care and procedures is equal and ensured as a right of
beneficiary status, and socioeconomic differences between
patients are minimized, the utilization of invasive cardiac
procedures and outcome after AMI is determined by clinical
variables exclusive of race. We did identify an increased
likelihood of white patients to be “considered” for catheter-
ization more frequently than nonwhite patients, suggesting
Figure 1. Estimated odds ratios (squares)
and 95% confidence intervals (horizontal
bars) for cardiac catheterization during
the index AMI admission according to
various patient characteristics. Estimated
odds ratios as indicated are adjusted for
other variables (see Methods).
Table 3. Estimated Odds Ratios for Outcome Variables According
to Ethnic Group in Patients with Acute Myocardial Infarction in the
Civilian External Peer Review Program
Outcome
Estimated OR*
(95% CI)
p
Value
White vs. nonwhite pts
Mortality
30 days 0.91 (0.51–1.66) 0.77
180 days 0.99 (0.57–1.74) 0.99
Hospital readmission within 180 days 1.05 (0.48–2.29) 0.91
White vs. black pts
Mortality
30 days 1.04 (0.47–2.27) 0.93
180 days 1.04 (0.51–2.12) 0.92
Hospital readmission within 180 days 1.02 (0.39–2.7) 0.96
White vs. nonblack ethnic pts
Mortality
30 days 0.76 (0.32–1.80) 0.53
180 days 0.92 (0.39–2.13) 0.84
Hospital readmission within 180 days 1.04 (0.40–2.72) 0.94
*Estimated odds ratios were derived by multiple logistic regression, with
each ratio adjusted for patient demographic and acute myocardial infarction
variables (see Methods). An estimated odds ratio ,1 indicates that a white
patient was less likely to experience the indicated outcome than a nonwhite
patient with the same characteristics, and a ratio .1 indicates that white patients
had a higher odds. Abbreviations as in Table 2.
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that within the physician/patient interaction, a differential
association with race is discernible. However, in this low risk
group few patients actually underwent subsequent cardiac
catheterization, indicating that the overriding determinant of
the utilization of cardiac catheterization was the clinical status
of the patient and not race. In contrast to data from the
Myocardial Infarction Triage and Interventional Registry (14),
in which nonwhite patients had lower rates of coronary revas-
cularization despite similar rates of cardiac catheterization, we
did not observe an association of race and the use of coronary
revascularization procedures. The finding that socioeconomic
status as measured by military rank had no effect on our
models confirms the absence of significant socioeconomic
barriers to care in our population.
Origins and solutions for ethnic bias in access to cardio-
vascular procedures. The etiology of the previously observed
differences between white and nonwhite patients in access to
cardiovascular procedures is unknown and controversial, with
the possibility that the differences have a racial etiology at the
center of the issue. In particular, the isolation of race from
socioeconomic status has proved difficult. Studies from the
VAMS and Medicare have attempted to do this by evaluating
the impact of race within the relatively socioeconomically
homogeneous populations they serve. Data from the VAMS
(7), a system postulated to overcome many of the above
limitations, particularly those related to socioeconomic status,
access to care and financial motives, indicated a nearly twofold
increase in the rate of cardiac catheterization for white versus
black patients with a primary diagnosis of cardiovascular
disease or chest pain. However, the strength of the conclusion
that this difference is solely attributable to race remains limited
because the VAMS is not completely free of access barriers,
such as geographic separation, to care and medications. These
data also may be limited in their generalizability because the
VAMS serves a higher proportion of poor and indigent
patients than the civilian health care system. Nonetheless,
other recent data (9) on the use of health services by Medicare
beneficiaries supports a racial bias in the use of elective
coronary revascularization procedures. This bias was reduced,
but not corrected, by a broad adjustment for income level.
A further limitation to the above conclusions derived from
largely administrative databases comes from the lack of rele-
vant clinical information on which they are based. In an effort
to address this limitation, a recent report from Peterson et al.
(11) reported persistence of racial differences in use of cardio-
vascular procedures after broad correction for clinical charac-
teristics, yet adjustments for socioeconomic differences were
not made in their study.
Our study cannot isolate the responsible factors that elim-
inated ethnic bias in our study sample. Specific factors may
include the absence of financial barriers to accessing the health
care system, the absence of provider financial incentives and
relative socioeconomic parity among patients. However, per-
haps the most important lesson from our data is not the
specific characteristics or factors that relate to the use of
cardiac catheterization after AMI, but rather the characteris-
tics of a health care system in which ethnic inequities in access
to health services are eliminated.
Many of the characteristics of the MHSS are those found
within systems of managed care. The MHSS can be character-
ized as a large, nationwide, staff-model managed care plan with
some financial barriers, such as CHAMPUS co-pays, to access-
ing providers outside the system. Furthermore, the MHSS is
globally budgeted and is indefinitely “at risk” from both a
financial and resource utilization standpoint for the outcomes
of its beneficiaries. Thus, the “system” may act to minimize
ethnic differences in health care utilization in that the system’s
interests are best served by taking the best care of its benefi-
ciaries. Admittedly, differences between the MHSS and health
maintenance organizations do exist and include the cultural
influence of rank in a military organization. Health mainte-
nance organizations are also subject to pressures under the
motive of profitability of the system and are more likely to
experience a high degree of beneficiary turnover. Thus, this
hypothesis, that a health care system such as a health mainte-
nance organization possesses characteristics that could limit
ethnic inequities in access to health services, is deserving of
future study. Promise for this hypothesis is found in recent data
(15) from the Kaiser Permanente Medical Care Program
demonstrating that a health care system can exert a positive
influence to reduce the variability between hospitals in proce-
dural utilization after AMI.
Limitations of the study. Our detailed abstracted chart
review data had the advantage of containing accurate clinical
information, enabling us to control for AMI severity by consid-
ering data such as peak CK level and the presence of congestive
heart failure or ventricular arrhythmias, known markers of in-
creased risk after AMI. Although this represents an improvement
over most previous studies on racial bias in cardiovascular proce-
dures that have relied primarily on administrative data, other
prognostic measures, such as left ventricular ejection fraction,
were not available. However, outcomes over 180 days, a period of
time relevant to heightened risk after AMI (16,17), were compa-
rable among patient groups. Despite comparable outcomes with
respect to “hard” events (death and readmission), it is unknown
whether other outcomes such as frequency of angina, functional
status or quality of life were comparable. Furthermore, these data
are relevant to the issue of racial bias in access to invasive
cardiovascular procedures. Although such procedures are readily
identifiable and therefore lend themselves to study, they repre-
sent just a single patient management decision. Thus, the absence
of racial bias throughout the entirety of the patient/physician
interaction cannot be assumed.
Our study is relatively small compared with previously re-
ported experience from administrative databases. However, post
hoc analysis indicated that our sample had a power of 0.85 (beta
0.15) to detect an odds ratio for in-hospital catheterization
between white and nonwhite patients of 1.3 and a power of 0.96
(beta 0.04) for a similar difference in 180-day catheterization.
Alternatively, attention to the 95% confidence intervals (18) of
the estimated odds ratio indicates that, for 180-day cardiac
catheterization, the data are consistent with a “true” odds ratio of
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between 0.77 and 1.49. Thus, our sample had sufficient power to
detect a difference comparable to that previously described in the
utilization rates of cardiac catheterization (1,2). Broader confi-
dence intervals are seen in our subgroup comparisons of white
versus black and nonblack ethnic patients. Thus, caution is
advised in the interpretation of these results. Future studies
including larger numbers of patients, particularly nonblack ethnic
patients, would be helpful in this regard. Furthermore, future
studies would be improved by the analysis of ethnic differences in
the use of cardiovascular procedures in diagnostic groups other
than AMI, such as angina pectoris, as recently performed by
Peterson et al. (11). The possible effect of selection bias should be
minimized because the study included all patients with a primary
or secondary diagnosis of AMI during the predefined sampling
period.
One concern with the use of MHSS data for health services
research centers on the issue of generalizability. With respect to
age and race, these patients were similar to adults (.21 years old)
with AMIs in the 1990 National Hospital Discharge Survey
(NHDS) (19). In that population, the mean age was 62.9 6 18.0
years (range 22 to 991), 84.1% were white, 13.2% were black,
and 2.7% were of other race. However, in the NHDS, only 42.9%
were men, significantly less than we found in the MHSS data (p ,
0.01). To address this discrepancy, we adjusted our models for any
potential effect of gender. The general processes of care in MHSS
and civilian hospitals are also similar. A review of the distribution
of diagnosis-related groups (DRGs) in the two health systems
reveals that the relative ranks of the 420 most common DRGs are
comparable (Spearman’s rho 0.71). Finally, although the rate of
cardiac catheterization observed in the present study (35.5%
during the initial hospital period and 44.4% by 180 days) is higher
than that reported from the VAMS (7), these data are consistent
with data from patients assigned to conservative management
after AMI, as reported in the second Thrombolysis in Myocardial
Infarction Trial (17).
Conclusions. Both physician vigilance and patient education
should be essential measures toward ensuring that medical ap-
propriateness is the sole determinant of access to health care.
With recent studies indicating a lack of progress in the advance-
ment of ethnic parity in access to cardiovascular procedures
despite 20 years of education of health care workers and patients
on this important societal issue, the time may have arrived for
health care systems to participate in solving this problem. Our
data, which require confirmation in larger studies, raise the
promise that characteristics of a health care system can mitigate
the pervasive tendency toward ethnic inequity in medicine.
We acknowledge the Forensic Medical Advisory Service of Rockville, Maryland
for their assistance in collecting the CEPRP data, and Colonel David Shutt,
USAF, MC of the Quality Assurance Office, Department of Defense, Health
Affairs, who supervised the collection and analysis of these data.
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